Aura Biosciences (AURA) Change in Account Payables (2020 - 2026)
Aura Biosciences (AURA) reported Change in Account Payables of $1.0 million for Q1 2026, up 443.62% on a YoY basis from $188365.4 in Q1 2025, and up 338.14% quarter-over-quarter from -$430000.0 in Q4 2025.
Aura Biosciences (AURA) Change in Account Payables (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Change in Account Payables for 7 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 443.62% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $476000.0 (up 195.65% YoY), and the FY2025 full-year result was -$846000.0, down 275.52% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.0 million, up from -$430000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.0 million in Q1 2026, with the low at -$1.9 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$2352.9 across 5 years, with a median of $23000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 524.54% — and 2025, when it plunged 1395.65%.
- Aura Biosciences' Change in Account Payables stood at $1.0 million in 2022, then slumped by 55.11% to $457000.0 in 2023, then sank by 32.17% to $310000.0 in 2024, then tumbled by 238.71% to -$430000.0 in 2025, then soared by 338.14% to $1.0 million in 2026.
- The last three Change in Account Payables figures came in at $1.0 million (Q1 2026), -$430000.0 (Q4 2025), and $602000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | -430,000.00 |
| Dec 31, 2025 | -430,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Sep 30, 2025 | 602,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Mar 31, 2025 | -298,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Dec 31, 2024 | 310,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Jun 30, 2024 | -540,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 457,000.00 |
| Dec 31, 2023 | 457,000.00 |